Testing effectiveness (Phase 2)Study completedNCT05576623
What this trial is testing
Safety and Immunogenicity of AdCLD-CoV19-1 OMI as a Booster: A SARS-CoV-2 (COVID-19) Preventive Vaccine
Who this might be right for
COVID-19Vaccines
Cellid Co., Ltd. 320